IR News

Apr 11, 2025 For 2nd quarter FY8 2025 Financial Results Presentation （1,132KB）

Apr 11, 2025 Non-consolidated Financial Results for the Six Months Ended February 28, 2025 [Japanese GAAP] （442KB）

Apr 01, 2025 Presentation of data from our pipeline at the American Association for Cancer Research Annual Meeting 2025 （233KB）

Jan 14, 2025 Non-consolidated Financial Results for the Three Months Ended November 30, 2024 [Japanese GAAP] （432KB）

Jan 10, 2025 Rogocekib for the treatment of Refractory or Relapsed Acute Myologic Lymphoma(AML) has been granted Orphan Drug Designation (ODD) in the US by the FDA （272KB）

Dec 12, 2024 By FISCO Corporation Notice of Distribution of Our Corporate Research Report （267KB）

Nov 29, 2024 Corporate Governance Report （659KB）

Nov 20, 2024 Announcement of International Nonproprietary Name (INN) for CTX-712 （277KB）

Oct 28, 2024 Chordia announces the Release of a Transcript of the Earnings Briefing for the Fiscal Year Ended August 2024 （281KB）

Oct 15, 2024 Fiscal year ended August 2024 Financial Results Presentation （1,465KB）

Oct 11, 2024 Non-consolidated Financial Results for the Fiscal Year Ended August 31, 2024 [Japanese GAAP] （538KB）

Oct 11, 2024 Chordia to Present Results of Phase 1 Clinical Trial of CLK Inhibitor CTX-712 at the 2024 The 86th Annual Meeting of the Japanese Society of Hematolog （283KB）

Oct 01, 2024 Announcement of Presentation on Phase 1 Clinical Trial of CLK Inhibitor CTX-712 at the 86th Annual Meeting of the Japanese Society of Hematology （281KB）

Jul 23, 2024 Chordia wins the Minister of Education, Culture, Sports, Science and Technology Award at the Japan Startup Awards 2024. （610KB）

Jul 16, 2024 Non-consolidated Financial Results for the Nine Months Ended May 31, 2024 [Japanese GAAP] （348KB）